Unknown

Dataset Information

0

Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors.

ABSTRACT: A series of macrocyclic pyrido-pentapeptide candidates 2?6 were synthesized by using N,N-bis-[1-carboxy-2-(benzyl)]-2,6-(diaminocarbonyl)pyridine 1a,b as starting material. Structures of the newly synthesized compounds were established by IR, ¹H and 13C-NMR, and MS spectral data and elemental analysis. The in-vitro cytotoxicity activity was investigated for all compounds against MCF-7 and HepG-2 cell lines and the majority of the compounds showed potent anticancer activity against the tested cell lines in comparison with the reference drugs. Out of the macrocyclic pyrido-pentapeptide based compounds, 5c showed encouraging inhibitory activity on MCF-7 and HepG-2 cell lines with IC50 values 9.41 ± 1.25 and 7.53 ± 1.33 ?M, respectively. Interestingly, 5c also demonstrated multitarget profile and excellent inhibitory activity towards VEGFR-2, CDK-2 and PDGFR? kinases. Furthermore, molecular modeling studies of the compound 5c revealed its possible binding modes into the active sites of those kinases.

SUBMITTER: Amr AEE 

PROVIDER: S-EPMC6222410 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors.

Amr Abd El-Galil E AEE   Abo-Ghalia Mohamed H MH   Moustafa Gaber O GO   Al-Omar Mohamed A MA   Nossier Eman S ES   Elsayed Elsayed A EA  

Molecules (Basel, Switzerland) 20180920 10

A series of macrocyclic pyrido-pentapeptide candidates <b>2</b>⁻<b>6</b> were synthesized by using <i>N</i>,<i>N</i>-bis-[1-carboxy-2-(benzyl)]-2,6-(diaminocarbonyl)pyridine <b>1a</b>,<b>b</b> as starting material. Structures of the newly synthesized compounds were established by IR, ¹H and <sup>13</sup>C-NMR, and MS spectral data and elemental analysis. The in-vitro cytotoxicity activity was investigated for all compounds against MCF-7 and HepG-2 cell lines and the majority of the compounds sho  ...[more]

Similar Datasets

Unknown Design, synthesis, anticancer activity and docking studies of novel quinazoline-based thiazole derivatives as EGFR kinase inhibitors.
| S-EPMC10560058 | biostudies-literature
Unknown Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors.
| S-EPMC5151143 | biostudies-literature
Unknown Angular Phenozaxine Ethers as Potent Multi-microbial Targets Inhibitors: Design, Synthesis, and Molecular Docking Studies.
| S-EPMC5712349 | biostudies-literature
Unknown Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold.
| S-EPMC6009920 | biostudies-literature
Unknown Design, Synthesis, and Docking Studies of New Torin2 Analogs as Potential ATR/mTOR Kinase Inhibitors.
| S-EPMC6102578 | biostudies-literature
Unknown Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking Studies.
| S-EPMC8157871 | biostudies-literature
Unknown Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers.
| S-EPMC8344243 | biostudies-literature
Unknown Novel piperazine-chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation.
| S-EPMC7758046 | biostudies-literature
Unknown Design, synthesis, anticancer activity and docking studies of theophylline containing 1,2,3-triazoles with variant amide derivatives.
| S-EPMC6072493 | biostudies-other
Unknown In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs.
| S-EPMC6960140 | biostudies-literature